Japan's Asahi Kasei to buy Danish pharma Veloxis for $1.3b

Japan's Asahi Kasei to buy Danish pharma Veloxis for $1.3b

Hideki Kobori, president of Asahi Kasei Corp., poses for a photograph in Tokyo, Japan, on Friday, Dec. 8, 2017. Photographer: Akio Kon/Bloomber

Asahi Kasei Corp. is buying Denmark’s Veloxis Pharmaceuticals A/S for 143.2 billion yen ($1.3 billion), the companies said, in the latest of a series of deals by Japanese drugmakers.